Find uplifting stories about heroes, innovations, and solutions
11 results for "cancer vaccine"
Scientists at UCLA have achieved breakthrough results in treating advanced colorectal cancer, with a new combination therapy doubling two-year survival rates. The research team is also making major strides in prevention, from mailing free screening kits to developing powerful cancer vaccines.
A personalized mRNA vaccine helped 11 women with aggressive breast cancer stay cancer-free for up to six years. The groundbreaking treatment trained their immune systems to recognize and fight cancer cells using their own tumor's genetic code.
Scientists have developed a therapeutic vaccine that successfully fought HPV-related cancers in mice, offering hope for patients with advanced disease. Unlike current vaccines that only prevent infection, this treatment targets existing tumors.
Scientists have designed a cancer vaccine that successfully fought HPV-related throat tumors in mice, offering hope for people battling these aggressive cancers. The breakthrough lies in how the vaccine's components are arranged, making it more effective at training the immune system to recognize and destroy cancer cells.
Kenya just made one of the world's most preventable cancers far easier to stop. A single HPV shot now protects girls for life, removing the biggest barriers to vaccination.
Every woman from a small 2000s breast cancer vaccine trial is alive today, decades past typical survival odds. Scientists now know why their immune systems stayed cancer-ready for 20 years.
A groundbreaking cancer vaccine is teaching the immune system to destroy abnormal cells before they become tumors in high-risk patients. Five major research breakthroughs from MD Anderson are reshaping how doctors prevent and treat cancer.
A woman's dog detected her breast cancer by pressing his nose to a lump on her chest. Now she's part of a groundbreaking vaccine trial that could prevent aggressive breast cancer from returning.
After decades of limited success, cancer vaccines are finally delivering real results thanks to breakthrough genetic technologies that customize treatment to each patient's unique tumor. When combined with other therapies, these personalized vaccines are showing promise across multiple cancer types.
A personalized mRNA cancer vaccine combined with immunotherapy reduced the risk of deadly skin cancer returning by nearly 50% over five years. The breakthrough treatment is now entering final-stage trials while researchers test similar vaccines for lung, bladder, and kidney cancers.
A Moderna immunotherapy for melanoma continues to protect patients years after treatment, new data shows. The results bring hope for a cancer vaccine that could change how we fight one of the deadliest skin cancers.